Defective Bax activation in Hodgkin B-cell lines confers resistance to staurosporine-induced apoptosis.
Kashkar, H
Defective Bax activation in Hodgkin B-cell lines confers resistance to staurosporine-induced apoptosis. [electronic resource] - Cell death and differentiation Jul 2002 - 750-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1350-9047
10.1038/sj.cdd.4401024 doi
Apoptosis
B-Lymphocytes--cytology
Caspase 3
Caspases--metabolism
Drug Resistance
Enzyme Activation
Enzyme Inhibitors--pharmacology
Hodgkin Disease
Humans
Mitochondria
Protein Kinase C--antagonists & inhibitors
Proto-Oncogene Proteins--metabolism
Proto-Oncogene Proteins c-bcl-2
Signal Transduction
Staurosporine--pharmacology
Tumor Cells, Cultured
bcl-2-Associated X Protein
Defective Bax activation in Hodgkin B-cell lines confers resistance to staurosporine-induced apoptosis. [electronic resource] - Cell death and differentiation Jul 2002 - 750-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1350-9047
10.1038/sj.cdd.4401024 doi
Apoptosis
B-Lymphocytes--cytology
Caspase 3
Caspases--metabolism
Drug Resistance
Enzyme Activation
Enzyme Inhibitors--pharmacology
Hodgkin Disease
Humans
Mitochondria
Protein Kinase C--antagonists & inhibitors
Proto-Oncogene Proteins--metabolism
Proto-Oncogene Proteins c-bcl-2
Signal Transduction
Staurosporine--pharmacology
Tumor Cells, Cultured
bcl-2-Associated X Protein